- Home
- AUGO vs LIVN Comparison
AUGO vs LIVN Comparison
Compare AUGO & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUGO
- LIVN
- Stock Information
- Founded
- AUGO 1946
- LIVN 1987
- Country
- AUGO United States
- LIVN United Kingdom
- Employees
- AUGO N/A
- LIVN N/A
- Industry
- AUGO
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AUGO
- LIVN Health Care
- Exchange
- AUGO Nasdaq
- LIVN Nasdaq
- Market Cap
- AUGO 1.8B
- LIVN 2.1B
- IPO Year
- AUGO N/A
- LIVN 1993
- Fundamental
- Price
- AUGO $31.92
- LIVN $57.97
- Analyst Decision
- AUGO
- LIVN Strong Buy
- Analyst Count
- AUGO 0
- LIVN 7
- Target Price
- AUGO N/A
- LIVN $59.71
- AVG Volume (30 Days)
- AUGO 171.8K
- LIVN 653.4K
- Earning Date
- AUGO 08-06-2025
- LIVN 10-29-2025
- Dividend Yield
- AUGO 3.83%
- LIVN N/A
- EPS Growth
- AUGO N/A
- LIVN N/A
- EPS
- AUGO N/A
- LIVN N/A
- Revenue
- AUGO $679,914,000.00
- LIVN $1,309,329,000.00
- Revenue This Year
- AUGO $47.72
- LIVN $11.29
- Revenue Next Year
- AUGO $47.89
- LIVN $6.59
- P/E Ratio
- AUGO N/A
- LIVN N/A
- Revenue Growth
- AUGO 35.59
- LIVN 8.23
- 52 Week Low
- AUGO $22.24
- LIVN $32.48
- 52 Week High
- AUGO $31.85
- LIVN $58.42
- Technical
- Relative Strength Index (RSI)
- AUGO N/A
- LIVN 74.15
- Support Level
- AUGO N/A
- LIVN $55.50
- Resistance Level
- AUGO N/A
- LIVN $56.70
- Average True Range (ATR)
- AUGO 0.00
- LIVN 1.34
- MACD
- AUGO 0.00
- LIVN 0.07
- Stochastic Oscillator
- AUGO 0.00
- LIVN 92.11
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.